Vanguard Group’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $39.7K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $43K | Sell |
|
|||||
|
2022
Q2 | $78K | Sell |
|
|||||
|
2022
Q1 | $341K | Hold |
|
|||||
|
2021
Q4 | $1.33M | Sell |
|
|||||
|
2021
Q3 | $1.41M | Buy |
|
|||||
|
2021
Q2 | $1.41M | Buy |
|
|||||
|
2021
Q1 | $591K | Buy |
|
|||||
|
2020
Q4 | $396K | Sell |
|
|||||
|
2020
Q3 | $434K | Sell |
|
|||||
|
2020
Q2 | $1.18M | Sell |
|
|||||
|
2020
Q1 | $533K | Hold |
|
|||||
|
2019
Q4 | $1.15M | Buy |
|
|||||
|
2019
Q3 | $924K | Sell |
|
|||||
|
2019
Q2 | $2.41M | Buy |
|
|||||
|
2019
Q1 | $3.03M | Buy |
|
|||||
|
2018
Q4 | $2.87M | Buy |
|
|||||
|
2018
Q3 | $5.47M | Hold |
|
|||||
|
2018
Q2 | $3.53M | Buy |
|
|||||
|
2018
Q1 | $3.36M | Buy |
|
|||||
|
2017
Q4 | $692K | Buy |
|
|||||
|
2017
Q3 | $416K | Buy |
|
|||||
|
2017
Q2 | $359K | Buy |
|
|||||
|
2017
Q1 | $674K | Buy |
|
|||||
|
2016
Q4 | $161K | Buy |
|
|||||
|
2016
Q3 | $166K | Sell |
|
|||||
|
2016
Q2 | $195K | Hold |
|
|||||
|
2016
Q1 | $216K | Sell |
|
|||||
|
2015
Q4 | $329K | Buy |
|
|||||
|
2015
Q3 | $566K | Hold |
|
|||||
|
2015
Q2 | $828K | Buy |
|